Clinically Severe Covid-19 Patients: How Do Laboratory Investigations Correlate Physicians’ Assessment?

Abstract
The latest pandemic of ‘Corona Virus Disease 2019′ caused by the virus SARS-CoV2 devastated communities worldwide from 2020 CE to 2022 CE. Health-care workers in the so-called Third-world countries had to deal with large number of patients with insufficient medical equipment and unavailable laboratory facilities. Therefore, clinical assessment criteria of the severity of the disease, co-established by WHO and CDC, became the cornerstone of management in the resource-poor setting societies. In this study, we evaluated the relevant laboratory tests performed during the hospital-stay of COVID-19 patients, and tried to identify which investigation-abnormalities were reflective of patients’ clinical severity. Higher scores in CT-scan of chest, high CRP, and low Lymphocyte count were very common among ‘severe’ COVID patients, while high Ferritin and high D-dimer were not uncommon as well.

Key Words: COVID-19, CT-chest, CRP, Lymphocytes

Request For Pdf Version of this Journal

Please enable JavaScript in your browser to complete this form.

Name *

First

Last

Institute Name

Designation *

Phone Number

Email *

Message *

Submit